Search Documents and Resources

  • Ethics
  • Accountability
  • COVID-19
  • More Topics
  • About
  • Mission & History
  • Board & Staff
  • Financials
  • Take Action
  • For Federal Employees
  • COVID-19: Tips
  • Contact Us
  • Privacy Policy
  • Subscribe
  • Donate
Project On Government Oversight
    • Mission & History
    • Board & Staff
    • Financials
    • Take Action
    • For Federal Employees
    • COVID-19: Tips
    • Contact Us
    • Privacy Policy
  • Subscribe
  • Donate
  • Ethics
  • More Topics
  • About
  • Mission & History
  • Board & Staff
  • Financials
  • Take Action
  • For Federal Employees
  • COVID-19: Tips
  • Contact Us
  • Privacy Policy
  • Subscribe
  • Donate
Project On Government Oversight
    • Mission & History
    • Board & Staff
    • Financials
    • Take Action
    • For Federal Employees
    • COVID-19: Tips
    • Contact Us
    • Privacy Policy
  • Subscribe
  • Donate
series

Drug Money

FDA user fee negotiations illustrate a broader phenomenon: the pharmaceutical industry’s influence over many institutions that are supposed to serve as checks on its interests.

Latest

Following the (Drug) Money

investigation | May 5, 2020

Read

Latest

Tainted Prescriptions: Big Pharma's Ties to Experts Advising Congress on Drug Costs

investigation | January 28, 2019

Read
  • FDA Set Low Bar for Approval of Blood Thinners

    analysis | December 12, 2016

  • FDA Depends on Industry Funding; Money Comes with “Strings Attached”

    investigation | December 1, 2016

  • In FDA Meetings, "Voice" of the Patient Often Funded by Drug Companies

    investigation | December 1, 2016

  • Drug Problems: Did Bad Blood Tests Turn a Clinical Trial into a Mistrial?

    analysis | March 15, 2016

  • Drug Problems: European Regulator Investigating Trial Led by FDA Nominee

    analysis | November 30, 2015

  • Drug Problems: Duke Reassessing Data From Trial Led By FDA Nominee

    analysis | November 20, 2015

  • Drug Problems: Nominee to Head FDA Led Clinical Trial FDA Faulted

    analysis | November 12, 2015

  • Drug Problems: Dangerous Decision-Making at the FDA

    investigation | October 15, 2015

Site Footer

  • facebook
  • twitter
  • instagram
  • youtube
  • Press Center
  • Contact Us
  • Careers
  • Training
  • Newsletters
  • Publications
  • Take Action
  • Report Corruption
Better Business Bureau Accredited Charity CharityWatch Top Rated Charity Great Nonprofits 2020 Top-Rated Charity Navigator Four-Star Charity

©2021 POGO | Privacy Policy

Project On Government Oversight logo

Project On Government Oversight